Immediate Impact
39 standout
Citing Papers
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
2024 Standout
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
2024 Standout
Works of Xuemei Ye being referenced
miR‑221‑3p and miR‑222‑3p regulate the SOCS3/STAT3 signaling pathway to downregulate the expression of NIS and reduce radiosensitivity in thyroid cancer
2021
Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Xuemei Ye | 55 | 77 | 27 | 88 | 74 | 35 | 323 | |
| Jiacheng Shen | 57 | 81 | 34 | 39 | 26 | 32 | 339 | |
| M. Hajduga | 70 | 69 | 31 | 18 | 55 | 21 | 302 | |
| Mengda Zhang | 14 | 57 | 9 | 53 | 21 | 32 | 304 | |
| Qiqiang Zhang | 10 | 59 | 15 | 13 | 167 | 35 | 306 | |
| Satoshi Nishida | 16 | 127 | 98 | 23 | 21 | 20 | 337 | |
| Huan Yu | 56 | 75 | 17 | 6 | 29 | 37 | 281 | |
| Jiefang Wang | 5 | 97 | 31 | 19 | 51 | 21 | 271 | |
| Guolin Hu | 5 | 66 | 88 | 28 | 20 | 22 | 316 | |
| Hideaki Nagashima | 11 | 47 | 29 | 35 | 33 | 37 | 260 | |
| Jiarui Hu | 8 | 80 | 22 | 11 | 21 | 34 | 287 |
All Works
Loading papers...